Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 81

Sort by

Sort Order Select

Journal Articles

Natural History Study of Idiopathic Multicentric Castleman Disease Identifies Effective Treatments for a Large Proportion of Patients but Treatment-Refractory Patients Remain

Blood (2019) 134 (Supplement_1): 1540.

https://doi.org/10.1182/blood-2019-131367

Published: 2019

Journal Articles

High Serum VEGF Level in Erdheim-Chester Disease: Correlation with Cardiovascular Involvement and Response to Treatment

Anaïs Roeser, MD, Marine Bravetti, MD, Levi-Dan Azoulay, MD, Makoto Miyara, MD, Jean-François Emile, MD, Jean Donadieu, MD PhD, Zahir Amoura, MD MSc, Fleur Cohen-Aubart, MD PhD, Julien Haroche

Blood (2019) 134 (Supplement_1): 2324.

https://doi.org/10.1182/blood-2019-129984

Published: 2019

Journal Articles

High Rate of Exclusion of HIV Infected Patients from Modern Lymphoma Studies: An Analysis of Current United States Therapeutic Trials

Manoj P. Menon, MD, Victor A. Chow, MD, Adam Greenbaum, MD PhD, Ryan C. Lynch, MD, Mazyar Shadman, MD MPH, Andrei Shustov, MD, Stephen D. Smith, MD, Brian G. Till, MD, Yolanda D. Tseng, MD, Chaitra S. Ujjani, MD, Thomas S. Uldrick, MD MS, Edus H. Warren, MD PhD, Ajay K. Gopal, MD

Blood (2019) 134 (Supplement_1): 4733.

https://doi.org/10.1182/blood-2019-127505

Published: 2019

Journal Articles

Ethical Issues and Barriers for Multi-National Paediatric Clinical Trials: The Challenging Experience of the DEEP Project

Viviana Giannuzzi, PhD, Mariagrazia Felisi, PhD, Hugo Devlieger, Aurelio Maggio, MD, George Papanikolaou, MD PhD, Giorgio Reggiardo, Bianca Tempesta, PhD, Fernando Tricta, MD, Donato Bonifazi

Blood (2019) 134 (Supplement_1): 4820.

https://doi.org/10.1182/blood-2019-124689

Published: 2019

Journal Articles

Patients with Sickle Cell Disease and Venous Thromboembolism Experience Increased Frequency of Vasoocclusive Events

Romy Carmen Lawrence, MD BS, Sarah L Khan, MD, Vishal Gupta, MD, Brittany Scarpato, MD, Rachel Strykowski, MD, Julia Newman, MD, John Mark Sloan, MD, Robyn T. Cohen, MD MPH, Seyed Mehdi Nouraie, PhD MD, Elizabeth S Klings, MD

Blood (2019) 134 (Supplement_1): 999.

https://doi.org/10.1182/blood-2019-122199

Published: 2019

Journal Articles

Phase I/II Study of Lenalidomide Combined with DA-EPOCH and Rituximab (DA-EPOCH-R 2 ) in Primary Effusion Lymphoma in Patients with or without HIV

Kathryn Lurain, MDMPH, Ramya Ramaswami, MBBS,MPH, Anaida Widell, RN, Irene Ekwede, RN, Jomy George, PharmD, Maryalice Stetler-Stevenson, MD PhD, Mark Raffeld, MD, Constance M. Yuan, MD PhD, Joseph Ziegelbauer, PhD, Frank Maldarelli, MD PhD, William D. Figg, PharmD, Cody Peer, PhD, Seth M. Steinberg, PhD, Denise Whitby, Thomas S. Uldrick, MD MS, Robert Yarchoan, MD

Blood (2019) 134 (Supplement_1): 4096.

https://doi.org/10.1182/blood-2019-122070

Published: 2019

Journal Articles

Recurrent Venous and Arterial Thrombosis By Prothrombin p.R596Q Heterozygous Mutation in a Chinese Patient: A Case Report and Literature Review

Rong-Fu Zhou, PhD MD, WANG JUN, MD, Xu Peng, MD, Hui Zeng, MD, Yong Xu, PhD, Yueyi Xu, MD, Min Zhou, Peipei Xu, Bing Chen

Blood (2019) 134 (Supplement_1): 4947.

https://doi.org/10.1182/blood-2019-130459

Published: 2019

Journal Articles

The Effect of Anticoagulant Choice on Venous Thromboembolism Recurrence and Bleeding in Sickle Cell Disease

Vishal K Gupta, MD, Romy Carmen Lawrence, MD BS, Sarah L. Khan, Rachel Strykowski, MD, Brittany Scarpato, MD, Robyn T. Cohen, MD MPH, John Mark Sloan, MD, Elizabeth S Klings, MD

Blood (2019) 134 (Supplement_1): 2272.

https://doi.org/10.1182/blood-2019-122113

Published: 2019

Journal Articles

High Incidence and Recurrence Rate of Venous Thromboembolic Events in Patients with Sickle Cell Disease

Bart J. Biemond, MD PhD, Ewout R. Egner, MD, Erfan Nur, MD PhD, Charlotte F.J. Van Tuijn, MPH, PhD

Blood (2018) 132 (Supplement 1): 2381.

https://doi.org/10.1182/blood-2018-99-119343

Published: 2018

Journal Articles

Mass Spectrometry-Based Immunopeptidome Analysis of Acute Myeloid Leukemia Cells Under Decitabine Treatment Delineates Induced Presentation of Cancer/Testis Antigens on HLA Class I Molecules

Jens Bauer, Nora Zieger, Annika Nelde, Leon Bichmann, Helmut R. Salih, MD, Lothar Kanz, Hans-Georg Rammensee, Stefan Stevanovic, Juliane S. Walz

Blood (2018) 132 (Supplement 1): 5223.

https://doi.org/10.1182/blood-2018-99-113357

Published: 2018

Journal Articles

Somatic PRAME Deletions Are Associated with Decreased Immunogenicity, Apoptosis Resistance and Poor Outcomes in Diffuse Large B-Cell Lymphoma

Katsuyoshi Takata, MD PhD, Daisuke Ennishi, MDPhD, Ali Bashashati, Saeed Saberi, Elena Viganò, PhD, Shannon Healy, PhD, Julie S Nielsen, Gianluca D' Antonio, Brad H Nelson, Sohrab P Shah, Joseph M Connors, Randy D. Gascoyne, MD, David W. Scott, PhDMD,FRACP,FRCPA, Christian Steidl, MD

Blood (2018) 132 (Supplement 1): 667.

https://doi.org/10.1182/blood-2018-99-113516

Published: 2018

Journal Articles

TFDP3 and DDX53 are Highly Re-Expressed after One Cycle of Azacitidine in Myelodysplastic Syndrome Patients Achieving Complete Response: A Cancer Testis Antigen RNA-Seq Screening

Ana M Hurtado López, Tzu Hua Chen-Liang, Joaquín Panadero, Eduardo José Salido, MD, Victor Beltrán, Begoña Muiña, Noelia Navarro-Villamor, Inés Calabria, Ana Isabel Antón, Francisco José Ortuño, Vicente Vicente, MD PhD, Andres Jerez

Blood (2018) 132 (Supplement 1): 4340.

https://doi.org/10.1182/blood-2018-99-117851

Published: 2018

Journal Articles

Outcomes in Children with Severe Vasculopathy from Sickle Cell Anemia after Treatment with Chronic Transfusion, Surgical Revascularization and/or Allogenic Hematopoetic Stem Cell Transplantation

Courtney W. Johnson, MD MSc, Suvankar Majumdar, MBCHB, Andrew D. Campbell, MD, Suresh Magge, MD, Deepika S. Darbari, MD, Jennifer Webb, MD, Yaser A. Diab, MBBS, Robert Sheppard Nickel, MDMSc, Barbara Speller-Brown, DNP, CPNP-BC, Jessica Carpenter, MD, Allistair Abraham, MD

Blood (2018) 132 (Supplement 1): 1098.

https://doi.org/10.1182/blood-2018-99-118693

Published: 2018

Journal Articles

Utilization of a Novel Method of Detection of CD30 Expression in Diffuse Large B-Cell Lymphoma

Oscar Calzada, BS, Kyle Bradley, MD MS, Jeffrey M. Switchenko, PhD MS, Christopher R Flowers, MD MS, Mary Jo Lechowicz, MD, Jean L. Koff, MD, Roberto Gianani, MD, Caroline Chandler, BA, Emily Mason, BA, Jonathon B. Cohen, MD MS

Blood (2018) 132 (Supplement 1): 2978.

https://doi.org/10.1182/blood-2018-99-116986

Published: 2018

Journal Articles

Azacitidine and Romidepsin Synergize to Induce Expression of Cancer Testes Antigens (CTA) and Shift Peripheral T-Cell Lymphoma (PTCL) Cell Lines Toward a Th1-like Phenotype

Cristina Kinahan, BS, Luigi Scotto, PhD, Owen A. O'Connor, MD, PhD

Blood (2018) 132 (Supplement 1): 2845.

https://doi.org/10.1182/blood-2018-99-117344

Published: 2018

Journal Articles

Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with DUSP22 rearrangements

Blood (2018) 132 (13): 1386–1398.

https://doi.org/10.1182/blood-2018-03-838524

Published: 2018

Includes: Supplemental data

Journal Articles

Global and Targeted RNA-Sequencing Assessment of Cancer Testis Antigen Re-Expression Following Azacitidine in Myelodysplastic Syndromes

Ana M Hurtado, Tzu Hua Chen-Liang, Joaquín Panadero, Eduardo José Salido, MD, Victor Beltrán, Begoña Muiña, Noelia Navarro-Villamor, Inés Calabria, Ana Isabel Antón, Andres Jerez

Blood (2017) 130 (Supplement 1): 1695.

https://doi.org/10.1182/blood.V130.Suppl_1.1695.1695

Published: 2017

Journal Articles

Altered Transcriptome Uniquely Associated with AML Vs. Normal Hematopoiesis

Yu Fan, Ying Hu, Cu Nguyen, Chunhua Yan, Rhonda E. Ries, MA, Hamid Bolouri, PhD, Jenny L. Smith, MSc, MD, Qingrong Chen, E. Anders Kolb, MD, Soheil Meshinchi, MD PhD, Daoud Meerzaman

Blood (2017) 130 (Supplement 1): 3792.

https://doi.org/10.1182/blood.V130.Suppl_1.3792.3792

Published: 2017

Journal Articles

Evaluation of Cancer Testis Antigens (CTAs) As Immuno-Therapeutic Targets in Pediatric AML

Rhonda E. Ries, MA, Jenny L. Smith, MSc, MD, Tim Triche, PhD, Jason E. Farrar, MD, Todd A Alonzo, PhD, Yussanne Ma, PhD, Lisa Wei, BS, Jaime Guidry Auvil, PhD, Daniela S. Gerhard, PhD, Marco A Marra, PhD, Alan S Gamis, MD MPH, Anders Kolb, MD, Hamid Bolouri, PhD, Soheil Meshinchi, MD PhD

Blood (2017) 130 (Supplement 1): 107.

https://doi.org/10.1182/blood.V130.Suppl_1.107.107

Published: 2017

Journal Articles

Unexplained Hypoxia and Shunting on Echocardiography in Patients with Sickle Cell Disease: A Retrospective Review

Payal C. Desai, MD, Nicole Kendel, MD, Melanie Heinlein, BS, Ying Huang, MA, MS, Eric H. Kraut, MD, Namita Sood, Subha Raman, MD

Blood (2016) 128 (22): 3673.

https://doi.org/10.1182/blood.V128.22.3673.3673

Published: 2016

NARROW

Natural History Study of Idiopathic Multicentric Castleman Disease Identifies Effective Treatments for a Large Proportion of Patients but Treatment-Refractory Patients Remain

High Serum VEGF Level in Erdheim-Chester Disease: Correlation with Cardiovascular Involvement and Response to Treatment

High Rate of Exclusion of HIV Infected Patients from Modern Lymphoma Studies: An Analysis of Current United States Therapeutic Trials

Ethical Issues and Barriers for Multi-National Paediatric Clinical Trials: The Challenging Experience of the DEEP Project

Patients with Sickle Cell Disease and Venous Thromboembolism Experience Increased Frequency of Vasoocclusive Events

Phase I/II Study of Lenalidomide Combined with DA-EPOCH and Rituximab (DA-EPOCH-R 2 ) in Primary Effusion Lymphoma in Patients with or without HIV

Recurrent Venous and Arterial Thrombosis By Prothrombin p.R596Q Heterozygous Mutation in a Chinese Patient: A Case Report and Literature Review

The Effect of Anticoagulant Choice on Venous Thromboembolism Recurrence and Bleeding in Sickle Cell Disease

High Incidence and Recurrence Rate of Venous Thromboembolic Events in Patients with Sickle Cell Disease

Mass Spectrometry-Based Immunopeptidome Analysis of Acute Myeloid Leukemia Cells Under Decitabine Treatment Delineates Induced Presentation of Cancer/Testis Antigens on HLA Class I Molecules

Somatic PRAME Deletions Are Associated with Decreased Immunogenicity, Apoptosis Resistance and Poor Outcomes in Diffuse Large B-Cell Lymphoma

TFDP3 and DDX53 are Highly Re-Expressed after One Cycle of Azacitidine in Myelodysplastic Syndrome Patients Achieving Complete Response: A Cancer Testis Antigen RNA-Seq Screening

Outcomes in Children with Severe Vasculopathy from Sickle Cell Anemia after Treatment with Chronic Transfusion, Surgical Revascularization and/or Allogenic Hematopoetic Stem Cell Transplantation

Utilization of a Novel Method of Detection of CD30 Expression in Diffuse Large B-Cell Lymphoma

Azacitidine and Romidepsin Synergize to Induce Expression of Cancer Testes Antigens (CTA) and Shift Peripheral T-Cell Lymphoma (PTCL) Cell Lines Toward a Th1-like Phenotype

Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with DUSP22 rearrangements

Global and Targeted RNA-Sequencing Assessment of Cancer Testis Antigen Re-Expression Following Azacitidine in Myelodysplastic Syndromes

Altered Transcriptome Uniquely Associated with AML Vs. Normal Hematopoiesis

Evaluation of Cancer Testis Antigens (CTAs) As Immuno-Therapeutic Targets in Pediatric AML

Unexplained Hypoxia and Shunting on Echocardiography in Patients with Sickle Cell Disease: A Retrospective Review

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only